Matthew Breyer

Company: Johnson & Johnson

Job title: Distinguished Scientist

Seminars:

Leveraging Single-Cell RNA Sequencing to Identify Untapped Molecular Pathways for Treatment of Chronic Kidney Disease 1:30 pm

• Utilizing single-cell RNA sequencing to forge a deeper understanding of drivers of disease • Harmonizing murine and human molecular responses to drug treatment of kidney disease • Defining cell-type specific responses to drug therapy in chronic kidney diseaseRead more

day: Track 1 - Day 2 PM

Panel Discussion: Interrogating Diverse Preclinical Models to Understand Pathophysiology & Screen Targets 12:00 pm

• Debating the best model: recapitulating complex architecture to test therapeutic efficacy • Tailoring disease models with patient-specific characteristics to execute precision medicine • From research to therapeutic application: bridging the translational gapRead more

day: Track 1 - Day 2 AM